Abbott (ABT) Tops Q2 EPS by 16c, FY EPS Guidance Tops Views

Abbott (NYSE: ABT) reported Q2 EPS of $0.57, $0.16 better than the analyst estimate of $0.41. Revenue for the quarter came in at $7.3 billion versus the consensus estimate of $6.75 billion.

GUIDANCE:

Abbott sees FY2020 EPS of at least $3.25, versus the consensus of $2.84.

• Abbott projects full-year 2020 diluted earnings per share from continuing operations under GAAP of at least $2.00. Abbott forecasts specified items for the full-year 2020 of $1.25 primarily related to intangible amortization, acquisition-related expenses, restructuring and cost reduction initiatives and other expenses. Excluding specified items, projected adjusted diluted earnings per share from continuing operations would be at least $3.25 for full-year 2020.

For earnings history and earnings-related data on Abbott (ABT) click here.

You May Also Be Interested In

• Wolfe Research Upgrades Abbott Labs (ABT) to Outperform
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c